Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

137.41
Delayed Data
As of 4:00pm ET
 +1.63 / +1.20%
Today’s Change
112.01
Today|||52-Week Range
169.89
-4.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues409.0M370.5M444.6M445.5M
 
 
 
 
 
Cost of Goods Sold20.6M6.4M11.2M11.8M
 
 
 
 
 
Depreciation And Amortization7.8M7.9M7.7M7.7M
 
 
 
 
 
 
Operating ExpensesGross Income380.6M356.2M425.7M426.0M
 
 
 
 
 
General Expenses206.4M92.6M127.2M102.2M
 
 
 
 
 
Research And Development66.9M36.2M59.8M55.0M
 
 
 
 
 
Total Operating Expenses234.8M106.9M146.1M121.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income174.2M263.6M298.5M323.8M
 
 
 
 
 
Extraordinary Charge0.000.00-256.5M-3.1M
 
 
 
Interest Expense On Debt2.2M800.0K1.4M3.3M
 
 
 
 
 
Other Expenses-500.0K800.0K3.6M3.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income171.5M263.6M44.2M320.7M
 
 
 
 
 
Income Taxes-61.2M-85.0M-100.2M-44.4M
 
 
 
 
 
Net Income110.3M178.6M-56.0M276.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.2M44.5M44.9M43.4M
 
 
 
 
 
Shares To Calculate EPS Diluted45.4M45.9M44.9M44.1M
 
 
 
 
 
 
Earnings Per ShareEPS$2.43$3.89-$1.25$6.27
 
 
 
 
 
EPS Diluted$2.43$3.89-$1.25$6.27